Item 1.01. Entry into a Material Definitive Agreement.
Chapter 11 Cases
As previously disclosed, on February 13, 2023, Sorrento Therapeutics, Inc.
("Sorrento" or the "Company") and its wholly-owned direct subsidiary, Scintilla
Pharmaceuticals, Inc. (together with the Company, the "Debtors"), commenced
voluntary proceedings under Chapter 11 of the United States Bankruptcy Code in
the United States Bankruptcy Court for the Southern District of Texas (the
"Bankruptcy Court"). The Debtors' Chapter 11 proceedings are jointly
administered under the caption In re Sorrento Therapeutics, Inc., et al., Case
Number 23-90085 (DRJ) (the "Chapter 11 Cases"). The Debtors continue to operate
their business in the ordinary course and in accordance with the applicable
provisions of the Bankruptcy Code and orders of the Bankruptcy Court.
Debtor-in Possession Financing
As previously disclosed, on February 19, 2023, the Debtors executed that certain
Debtor-In-Possession Term Loan Facility Summary of Terms and Conditions (the
"DIP Term Sheet") with JMB Capital Partners Lending, LLC ("JMB Capital" or the
"DIP Lender"), pursuant to which JMB Capital (or its designees or its assignees)
provided the Debtors with a non-amortizing super-priority senior secured term
loan facility in an aggregate principal amount not to exceed $75,000,000 in term
loan commitments (the "DIP Facility"), subject to the terms and conditions set
forth in the DIP Term Sheet.
As previously disclosed, at a hearing before the Bankruptcy Court on February
21, 2023, the Bankruptcy Court entered an interim order (the "Interim DIP
Order") approving the DIP Facility on an interim basis and providing the Debtors
with the necessary liquidity to continue to operate in Chapter 11. Upon entry of
the Interim DIP Order and satisfaction of all applicable conditions precedent,
as set forth in the DIP Term Sheet, the Debtors were authorized to make a
single, initial draw of $30,000,000 on the DIP Facility (the "Initial Draw").
The Debtors then negotiated definitive financing documentation, including a
Senior Secured, Super-Priority Debtor-in-Possession Loan and Security Agreement
(the "DIP Credit Agreement") and other documents evidencing the DIP Facility
(collectively with the DIP Credit Agreement, the "DIP Documents").
After a hearing before the Bankruptcy Court on March 29, 2023, the Bankruptcy
Court entered a final order (the "Final DIP Order") approving the DIP Facility
on a final basis and providing the Debtors with access to the remaining
$45,000,000 of the DIP Facility (subject to the terms, conditions, and covenants
set forth in the DIP Documents), through additional draws of no less than
$5,000,000, each upon five business days' written notice to the DIP Lender, and
the Debtors and DIP Lender proceeded to enter into the DIP Documents on March
30, 2023. Among other terms, the DIP Facility bears interest at a per annum rate
equal to 14% payable in cash on the first day of each month in arrears (and a
default interest rate that shall accrue at an additional per annum rate of 3%
plus the non-default interest, payable in cash on the first day of each month)
and other fees and charges as described in the DIP Documents. The DIP Facility
is secured by first-priority liens on substantially all of the Debtors'
unencumbered assets, subject to certain enumerated exceptions, and
second-priority liens on those assets of the Debtors that are encumbered by
certain permitted liens (as set forth in the Final DIP Order).
The DIP Facility matures on the earliest of: (i) July 31, 2023; (ii) the
effective date of any chapter 11 plan of reorganization with respect to the
Debtors; (iii) the consummation of any sale or other disposition of all or
substantially all of the assets of the Debtors pursuant to section 363 of the
Bankruptcy Code; (iv) the date of the acceleration of the DIP Loans and the
termination of the DIP Commitments in accordance with (and as defined in) the
DIP Documents; and (v) dismissal of the Chapter 11 Cases or conversion of the
Chapter 11 Cases into cases under chapter 7 of the Bankruptcy Code. The DIP
Facility does not contain a roll-up or cross-collateralization of prepetition
debt or otherwise dictate how prepetition claims will be addressed in a chapter
11 plan.
The foregoing summary of the DIP Facility is qualified in its entirety by
reference to the full text of the DIP Documents and the Final DIP Order. A copy
of the DIP Credit Agreement is attached to this Current Report on Form 8-K as
Exhibit 10.1 and incorporated by reference herein.
Additional information about the Chapter 11 Cases, including access to copies of
the Final DIP Order, the DIP Credit Agreement, and other documents filed with
the Bankruptcy Court, is available online at https://cases.stretto.com/sorrento,
a website administered by Stretto, a third-party bankruptcy claims and noticing
agent. The information on that website is not incorporated by reference into,
and does not constitute part of, this Current Report on Form 8-K.
Item 7.01. Regulation FD Disclosure.
Press Release
In connection with entry of the Final DIP Order, the Company issued a press
release on March 29, 2023, a copy of which is attached to this Current Report on
Form 8-K as Exhibit 99.1. Exhibit 99.1 is being furnished and shall not be
deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), or otherwise subject to the liabilities of that
section, nor shall such information be deemed incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Exchange Act,
whether made before or after the date hereof, except as shall be expressly set
forth by specific reference in such a filing.
Cautionary Statement Concerning Forward-Looking Statements
This Current Report on Form 8-K includes certain statements that are not
historical facts but are forward-looking statements for purposes of the safe
harbor provisions under the United States Private Securities Litigation Reform
Act of 1995. Forward-looking statements generally are accompanied by words such
as "believe," "may," "will," "estimate," "continue," "anticipate," "intend,"
"expect," "should," "would," "plan," "predict," "potential," "seem," "seek,"
"future," "outlook," and similar expressions that predict or indicate future
events or trends or that are not statements of historical matters. These
forward-looking statements include, but are not limited to, statements regarding
the future trading market for the Company's common stock, the Chapter 11 process
and the Chapter 11 Cases. The Company's actual results or outcomes and the
timing of certain events may differ significantly from those discussed in any
forward-looking statements. These statements are based on various assumptions
and on the current expectations of the Company's management and are not
predictions of actual performance. These forward-looking statements are provided
for illustrative purposes only and are not intended to serve as, and must not be
relied on by any investor as, a guarantee, an assurance, a prediction or a
definitive statement of fact or probability.
Actual events and circumstances are difficult or impossible to predict and will
differ from assumptions. Many actual events and circumstances are beyond the
control of the Company. These forward-looking statements are subject to a number
of risks and uncertainties, including risks associated with the unpredictability
of trading markets and whether a market will be established for the Company's
common stock; the potential adverse impact of the Chapter 11 Cases on the
Company's liquidity and results of operations; changes in the Company's ability
to meet its financial obligations during the Chapter 11 process and to maintain
contracts that are critical to its operations; the outcome and timing of the
Chapter 11 process; the effect of the Chapter 11 Cases on the Company's
relationships with vendors, regulatory authorities, employees and other third
parties; possible proceedings that may be brought by third parties in connection
with the Chapter 11 process; the timing or amount of any recovery, if any, to
the Company's stakeholders; the Company's ability to comply with the
restrictions imposed by the proposed terms and conditions of the DIP Facility;
trading of the Company's common stock on the Pink Open Market; and those factors
discussed in the Company's Annual Report on Form 10-K for the year ended
December 31, 2022 and subsequent Quarterly Reports on Form 10-Q filed with the
Securities and Exchange Commission, in each case under the heading "Risk
Factors," and other documents of the Company filed, or to be filed, with the
SEC. If the risks materialize or assumptions prove incorrect, actual results
could differ materially from the results implied by these forward-looking
statements. There may be additional risks that the Company presently does not
know or that the Company currently believes are immaterial that could also cause
actual results to differ from those contained in the forward-looking statements.
In addition, forward-looking statements reflect the Company's expectations,
plans or forecasts of future events and views as of the date of this document.
The Company anticipates that subsequent events and developments will cause its
assessments to change. However, while the Company may elect to update these
forward-looking statements at some point in the future, the Company specifically
disclaims any obligation to do so. These forward-looking statements should not
be relied upon as representing the Company's assessments as of any date
subsequent to the date of this document. Accordingly, undue reliance should not
be placed upon the forward-looking statements.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
10.1 Senior Secured, Super-Priority Debtor-In-Possession Loan and Security
Agreement, dated March 30, 2023, by and among Sorrento Therapeutics,
Inc., Scintilla Pharmaceuticals, Inc., and JMB Capital Partners
Lending, LLC.
99.1 Press Release, dated March 29, 2023, entitled "Sorrento Therapeutics,
Inc. Receives Final Court Approval for $75 Million Debtor-In-Possession
Financing."
104 Cover Page Interactive Data File, formatted in Inline Extensible Business
Reporting Language (iXBRL).
© Edgar Online, source Glimpses